2016
DOI: 10.1080/13691058.2016.1164899
|View full text |Cite
|
Sign up to set email alerts
|

When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling

Abstract: Oral pre-exposure prophylaxis (PrEP) using the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) has been shown to dramatically reduce the risk of HIV acquisition for women at higher risk of infection if taken daily. Understanding when and why women would intentionally stop using an efficacious oral PrEP drug within the context of their “normal” daily lives is essential for delivering effective PrEP risk-reduction counselling. We conducted 60 qualitative interviews with women at higher … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
36
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 53 publications
(41 citation statements)
references
References 26 publications
5
36
0
Order By: Relevance
“…General motives to temporarily or completely stop PrEP were in line with expectations, problems with uptake such as travelling, sickness and side‐effects, as noted in previous studies . The motives to temporarily stop daily PrEP or switch to event‐driven PrEP were primarily related to decreases in sexual risk behaviour.…”
Section: Discussionsupporting
confidence: 81%
See 2 more Smart Citations
“…General motives to temporarily or completely stop PrEP were in line with expectations, problems with uptake such as travelling, sickness and side‐effects, as noted in previous studies . The motives to temporarily stop daily PrEP or switch to event‐driven PrEP were primarily related to decreases in sexual risk behaviour.…”
Section: Discussionsupporting
confidence: 81%
“…The motives to temporarily stop daily PrEP or switch to event‐driven PrEP were primarily related to decreases in sexual risk behaviour. Our data therefore provide real‐life support to earlier data on intentions to use or stop PrEP, showing that PrEP users temporarily stopped daily PrEP as they found themselves in a non‐risky episode of their lives, a phenomenon referred to as “seasons of risk” , “seasons of vulnerability” and “seasons of PrEP ”. While some studies conceptualized such episodes of reduced intake as indication of non‐adherence to the daily regimen , we argue, among other authors , that such well‐informed decisions indicate self‐efficacy in managing PrEP‐regimens according to current risk level.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…Much qualitative research on antiretrovirals for prevention in Africa reports user perspectivesattitudes, knowledge, preferences, and influences on the use of PrEP and immediate ART [16][17][18][19][20][21][22][23][24][25][26]. Qualitative methods have also been used to shed light on reasons underlying suboptimal PrEP adherence in the VOICE and FEM-PrEP clinical trials [27][28][29][30][31][32].…”
Section: Discussionmentioning
confidence: 99%
“…Understanding the variety of product associations and PrEP perceptions of women with differing socioeconomic and geo-spatial locations catalyses an understanding of what women want and how to position microbicides for effective product introduction (see Namey et al 2016). The challenge remains for marketing experts to find a balance between what women want and to effectively tailor supporting promotional messages, delivery and distribution of products to varying users.…”
Section: Discussionmentioning
confidence: 99%